Original Article from The New England Journal of Medicine — Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

Fonte: Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis | NEJM

 Ainda em fase 2, mas resultados promissores …